-
PORTABILITY OF PERFORMANCE STATUS CALCULATIONS IN REAL-WORLD CANCER CARE
Mar 18, 2026, 21:38 PM -
AGENT-ATOM-GRADIENT: A NEXT-GEN AI ARCHITECTURE FOR EVIDENCE DRIVEN OUTCOMES RESEARCH
Mar 18, 2026, 21:38 PM -
PATIENT AND CAREGIVER PERSPECTIVES AND EXPECTATIONS OF PLAIN LANGUAGE SUMMARIES (PLS)
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF RADIOLIGAND THERAPY IN PSMA-POSITIVE MCRPC: INSIGHTS FROM REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN INTRA- AND POST-OPERATIVE SURGICAL COMPLICATIONS AND HEALTH ECONOMIC OUTCOMES IN PATIENTS UNDERGOING CESAREAN DELIVERY: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
MAPPING PATIENT-REPORTED OUTCOMES EVIDENCE REQUIREMENTS ACROSS GLOBAL MARKETS
Mar 18, 2026, 21:38 PM -
CLINICAL DEVELOPMENT LANDSCAPE AND CHARACTERISTICS OF RARE DISEASES IN THE U.S.
Mar 18, 2026, 21:38 PM -
MIXED METHODS OF DATA CAPTURE ARE AN ADVANCEMENT IN DETERMINING REAL-WORLD DEMENTIA TREATMENT EFFECTIVENESS, RETROSPECTIVELY-THE BEACON STUDY
Mar 18, 2026, 21:38 PM -
RISK OF MAJOR ADVERSE KIDNEY EVENTS OF TRIGLYCERIDE-TARGETING LIPID-LOWERING THERAPIES VERSUS STATINS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE IN CANADA: BASELINE ESTIMATES TO SUPPORT HEALTH TECHNOLOGY ASSESSMENT
Mar 18, 2026, 21:38 PM -
COST-CONSEQUENCE MODEL COMPARING ORIGINATOR R-HFSH-ALFA TO OTHER R-FSH-ALFA OPTIONS IN UP TO THREE COMPLETE OVARIAN STIMULATION CYCLES IN ASSISTED REPRODUCTIVE TECHNOLOGY IN CHINA
Mar 18, 2026, 21:38 PM -
TWO-YEAR COST ANALYSIS OF COMMON HEAD AND NECK CANCERS - INDEX PROCEDURES AND ADJUVANT THERAPIES
Mar 18, 2026, 21:38 PM -
SLEEP DISORDER DIAGNOSIS IN ADOLESCENCE AND SUBSEQUENT MENTAL HEALTH DIAGNOSES - A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN US PLATINUM-RESISTANT OVARIAN CANCER PATIENTS: CHARACTERIZING THE UNMET CLINICAL NEED
Mar 18, 2026, 21:38 PM -
PSYCHOTROPIC MEDICATIONS USE AND HIP FRACTURE RISK IN COMMUNITY-DWELLING OLDER ADULTS: A NESTED KNOWLEDGE ASSISTED META-ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF ACCESS TO THE FIRST OVER-THE-COUNTER ORAL CONTRACEPTIVE METHOD (OPILL) AMONG SEXUALLY ACTIVE ADULT WOMEN IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
INCORPORATING PUBLISHED SUBGROUP ANALYSES INTO MULTILEVEL NETWORK META-REGRESSION VIA BAYESIAN SYNTHETIC LIKELIHOOD
Mar 18, 2026, 21:38 PM -
SHEDDING LIGHT ON PATIENT-REPORTED OUTCOME MEASURE UTILIZATION ACROSS NSCLC THERAPIES
Mar 18, 2026, 21:38 PM -
MEASURING FUNCTIONAL ABILITIES AND ASSISTANCE LEVEL IN NIEMANN-PICK DISEASE TYPE C AND GM2 GANGLIOSIDOSES
Mar 18, 2026, 21:38 PM -
PATIENT JOURNEY FOUNDATIONAL MODEL FOR SCALABLE IMPUTATION OF MISSING UNITS OF MEASUREMENT (UOM) IN ELECTRONIC HEALTH RECORDS DATA
Mar 18, 2026, 21:38 PM
